Exicure, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
XCUR Company Description
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.
XCUR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view XCUR Smart Score
Score Breakdown
XCUR Company Description
Show More
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of XCUR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by XCUR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on XCUR's company Twitter account
WallStreetBets
Number of mentions of XCUR in WallStreetBets Daily Discussion
XCUR News
Recent insights relating to XCUR
CNBC Recommendations
Recent picks made for XCUR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in XCUR
Corporate Flights
Flights by private jets registered to XCUR
Our Analysis